Dvorak A M, Letourneau L, Weller P F, Ackerman S J
Department of Pathology, Beth Israel Hospital, Boston, Massachusetts.
Lab Invest. 1990 May;62(5):608-15.
Charcot-Leyden crystals (CLC), composed of a single protein with lysophospholipase activity, have been traditionally associated with eosinophil-rich disorders. Atypically shaped and typical CLC were noted by electron microscopy in the surgical sample from a patient with solid and papillary epithelial neoplasm of the pancreas. This rare primary tumor of the pancreas with limited aggressive behavior also contained damaged and partially or completely degranulated eosinophils in the tumor stroma. We localized CLC protein by ultrastructural immunogold staining to the CLC within vacuolar structures and in vesicles of tumor cell cytoplasm as well as to the cytoplasm and nucleus of eosinophils in the tumor stroma. These findings provide evidence that epithelial tumor cells contain Charcot-Leyden crystal protein that most likely originates from tumor stroma eosinophils. Tumor stroma eosinophils have generally been associated with improved prognoses in a wide variety of epithelial neoplasms. The role of tumor CLC protein (lysophospholipase) in these settings deserves further investigation.
夏科-莱登晶体(CLC)由具有溶血磷脂酶活性的单一蛋白质组成,传统上与富含嗜酸性粒细胞的疾病相关。在一名胰腺实性假乳头状上皮性肿瘤患者的手术样本中,通过电子显微镜观察到了形状异常和典型的CLC。这种侵袭性有限的罕见胰腺原发性肿瘤在肿瘤基质中还含有受损以及部分或完全脱颗粒的嗜酸性粒细胞。我们通过超微结构免疫金染色将CLC蛋白定位到液泡结构内和肿瘤细胞质囊泡中的CLC,以及肿瘤基质中嗜酸性粒细胞的细胞质和细胞核。这些发现提供了证据,表明上皮肿瘤细胞含有夏科-莱登晶体蛋白,其很可能起源于肿瘤基质中的嗜酸性粒细胞。肿瘤基质嗜酸性粒细胞通常与多种上皮性肿瘤的预后改善相关。肿瘤CLC蛋白(溶血磷脂酶)在这些情况下的作用值得进一步研究。